Format

Send to

Choose Destination
J Pharm Technol. 2012 Jul 1;28(4):156-162.

Cognitive Impairment and Medication Complexity in Community-Living Older Adults: The Health, Aging and Body Composition Study.

Author information

1
Section of Geriatrics, School of Medicine, Yale University, New Haven, CT; now, Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, Oregon State University/Oregon Health and Science University, Portland, OR.
2
Section of Geriatrics, School of Medicine, Yale University;
3
Division of Geriatric Medicine and Geriatric Research Education, University of Pittsburgh, and Clinical Center/Center for Health Equity Research and Policy, Pittsburgh Veterans Affairs Health Care System, Pittsburgh, PA;
4
Section of Geriatrics, School of Medicine, Yale University.
5
Division of General and Internal Medicine, University of California, San Francisco;
6
Department of Pharmaceutical Sciences, University of Tennessee, Memphis, TN;
7
Geriatric Epidemiology Section, Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD;
8
School of Pharmacy, University of Connecticut, Storrs, CT.

Abstract

BACKGROUND:

Medication complexity is a large determinant of adherence. Few studies have explored the relationship between cognitive impairment and medication complexity.

OBJECTIVE:

To evaluate whether cognitive impairment is associated with medication complexity for prescription and over-the-counter (OTC) medications.

METHODS:

In this cross-sectional analysis, we studied the association between cognitive impairment and the complexity of prescription and OTC drug regimens. Baseline participants were from the Health, Aging and Body Composition study, consisting of 3075 well-functioning 70- to 79-year-old black and white men and women. Cognitive impairment was defined by having a Modified Mini-Mental State Examination score <80. The complexity of prescription and OTC (including supplements/herbals) medications was assessed using a modified version of the Medication Regimen Complexity Index (mMRCI). The mMRCI score increases with complexity of dosage forms, number of medications, pill burden, and nondaily dosing.

RESULTS:

The mean (SD) age was 74 (2.9) years (n = 3055; 52% female, 41% black). The median prescription mMRCI score was 6 (range 0-66). The median OTC mMRCI score was 4 (range 0-71). Adjusting for health status, demographics, and access to care, medication complexity was lower in participants with cognitive impairment for prescription (adjusted RR 0.89; 95% CI 0.80 to 0.99) and OTC medications (adjusted RR 0.76; 95% CI 0.64 to 0.93) compared to those without cognitive impairment. The number of prescription medications was not different, but the number of OTC drugs was lower for those with cognitive impairment.

CONCLUSIONS:

In this cohort of well-functioning older adults, those with cognitive impairment had lower prescription complexity due to less-complex dosage forms, pill burden, or daily dosing. OTC complexity was also lower, primarily due to a lower number of OTC drugs. The results of this study show that further research on medication complexity and adherence and health outcomes in cognitively impaired individuals is warranted.

PMID:
24660166
PMCID:
PMC3959723

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center